<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="abstract" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Orthop J Sports Med</journal-id><journal-id journal-id-type="iso-abbrev">Orthop J Sports Med</journal-id><journal-id journal-id-type="pmc-domain-id">2603</journal-id><journal-id journal-id-type="pmc-domain">ojs</journal-id><journal-id journal-id-type="publisher-id">OJS</journal-id><journal-title-group><journal-title>Orthopaedic Journal of Sports Medicine</journal-title></journal-title-group><issn pub-type="epub">2325-9671</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12475670</article-id><article-id pub-id-type="pmcid-ver">PMC12475670.1</article-id><article-id pub-id-type="pmcaid">12475670</article-id><article-id pub-id-type="pmcaiid">12475670</article-id><article-id pub-id-type="doi">10.1177/2325967125S00283</article-id><article-id pub-id-type="publisher-id">10.1177_2325967125S00283</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Poster 191: Comparison of Quadriceps Autograft Versus Quadriceps Autograft Plus LET for ACL Reconstruction</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Economopoulos</surname><given-names initials="K">Kostas</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brinkman</surname><given-names initials="JC">Joseph C.</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Renfree</surname><given-names initials="S">Sean</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tummala</surname><given-names initials="SV">Sailesh V.</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hoffer</surname><given-names initials="A">Alex</given-names></name></contrib><aff id="aff1-2325967125S00283">Mayo Clinic Arizona</aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>13</volume><issue>9 suppl3</issue><issue-id pub-id-type="pmc-issue-id">497691</issue-id><issue-title>AOSSM Annual Meeting 2025</issue-title><elocation-id>2325967125S00283</elocation-id><pub-history><event event-type="pmc-release"><date><day>26</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 00:25:15.170"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For reprints and permission queries, please visit SAGE&#8217;s Web site at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sagepub.com/journalsPermissions.nav">http://www.sagepub.com/journalsPermissions.nav</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_2325967125S00283.pdf"/><abstract><sec id="section1-2325967125S00283"><title>Objectives:</title><p>To compare ACL reconstruction with quadriceps autograft with or without LET for primary ACL reconstruction</p></sec><sec id="section2-2325967125S00283"><title>Methods:</title><p>A retrospective study was performed from 2013- 2021 including patient undergoing quadriceps autograft (QA) or QA plus lateral extra-articular tenodesis (LET) for primary ACLR. Exclusion criteria included patients undergoing multi-ligamentous reconstruction, concomitant procedures outside of meniscal work, revision cases, and patients with less than 2 years of follow up. The surgeon favored LET in young (less than 18 years old) females participating in cutting and twisting sports. An additional relative indication was a high-grade pivot shift (2 or 3+). Clincal outcomes incldued IKDC and Lysholm scores, retrun to sport/return to sport at same level and time to return to sport in athletes along with complication rates. Failure rate was determined by rate of graft re-tearing and presence of a residual pivot shift (2+ or higher) at final follow up.</p></sec><sec id="section3-2325967125S00283"><title>Results:</title><p>A total of 142 patients underwent QA+LET with 18 excluded, leaving 124 patients in this group. The QA group had 371 patients with 57 excluded, leaving 314 for analysis. The QA+LET group had a significantly higher percentage of females, ligamentous laxity, and athletes. IKDC scores were significantly higher in the QA+LET group at final follow up. Lysholm scores were significantly higher in the QA group at 6 months, with no difference at other time points. Graft re-tear rates were similar between the 2 groups. Residual pivot shift at final follow up was significantly higher in the QA group (21% vs. 11%, p = 0.012) as was overall failure rate (24% vs. 14.5%. p = 0.026). Return to sport was similar between the 2 groups, but time to return to sport and return at the same or higher level was significantly higher in the QA+LET group. Hematomas were more common (12.9% vs. 0%) in the QA+LET group.&#8201;</p></sec><sec id="section4-2325967125S00283"><title>Conclusions:</title><p>Addition of an LET to QA leads to lower residual pivot shift when compared to QA alone. The addition of a LET to QA may lead to a higher return to sport at same or higher level compared to QA alone. This provides preliminary data that will be built upon with results from the Stability 2 trial.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts1</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>